Skip main navigation

Relief of symptoms

Aims of management of COPD.
Bronchodilator
© Inhaler by InspiredImages licensed CC0
Bronchodilators: Inhaled bronchodilators are central to symptom management in COPD and are the most common inhalers prescribed to reduce symptoms.

Based on the severity assessment of COPD, there are two types of bronchodilators: beta2-agonists and antimuscarinics. They both work in COPD and can be combined. Beta2-agnosist tend to be cheaper than antimuscarinics in most healthcare systems:

  1. Regular and as-needed use of short-acting beta2-agonist (SABA) or Short-acting antimuscarinic antagonist (SAMA)

  2. If symptoms persist, prescribe regular LABAs (Long-acting beta2-agonists) or LAMAs (Long-acting antimuscarinic antagonists)

  3. Combination treatment with a LABA and LAMA increases FEV1 and reduces symptoms compared to monotherapy.

The article below from NICE looks at the non-pharmacological management and use of inhaled therapies.

This article is from the free online

Chronic Respiratory Diseases (CRD) in Primary Care Settings

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now